E-posters - COVID research: Applying lessons from HIV prevention to SARS CoV-2
COVID research: Applying lessons from HIV preventi
•
EP7
•
>
•
E-posters - COVID research: Applying lessons from HIV prevention to SARS CoV-2
•
ePoster
COVID research: Applying lessons from HIV preventi
•
1056
•
COVID-19 and associated disruptions may indirectly affect HIV outcomes in two capital cities in Western/Central Africa: a modelling study
>
R.
Romain
SILHOL
•
1134
•
The impact of the COVID-19 pandemic on substance use and access to HIV prevention in Ukraine
>
K.
Kostyantyn
DUMCHEV
•
1147
•
In silico down-selection of T and B cell SARS-CoV-2 epitopes for improved dendritic cells targeting vaccine platform
>
M.
Mathieu Pierre
SURENAUD
•
1170
•
Sex work in the wake of SARSCoV2 in Zimbabwe: a qualitative study
>
F.
Fortunate
MACHINGURA
•
1176
•
Development of a probe to identify SARS-CoV2 infected cells in Rhesus Macaques
>
P.
Patrick
MADDEN
•
1199
•
An organotypic airway culture model for studying SARS-CoV-2 infection
>
M.
Mark
BECKER
•
1216
•
COVID-19 Vaccine Attitudes among Healthcare Workers in New York City: Preliminary Findings from the Antibody Response Monitoring for Occupational Resilience (ARMOR) Study
>
D.
Deborah
THEODORE
•
1258
•
COVID-19: A major challenge to Sex work in Nairobi, Kenya
>
M.
Maureen
AKOLO
•
1304
•
Elicitation of SARS-CoV 2 Spike protein-specific human IgG+ B cells following one dose of DNA-derived DREP and/or anti-CD40 Dendritic Cell (DC) targeting vaccine in a humanized mice model
>
V.
Veronique
GODOT
•
1367
•
Characterizing SARS-CoV-2 spread on college campuses
>
G.
Gage
MORENO
•
1459
•
Distinct humoral trajectories associated with both HIV co-infection and COVID-19 survival in a hospitalized South African SARS-CoV-2 cohort
>
S.
Simone
RICHARDSON
•
1468
•
Neutralization and Fc-mediated effector function against SARS-CoV-2 of engineered ACE2-Fc fusion
>
Y.
Yaozong
CHEN
•
1469
•
Learning from digital health in curtailing coronavirus epidemic: review of HIV/AIDS mobile apps or chatbots in Nigeria
>
M.
Miracle
ADESINA
•
1470
•
Characterization of the neutralizing antibody response in SARS-CoV-2 infected individuals
>
J.
Jeffrey
SCHNEIDER
•
1471
•
Shelter-in-place but at what cost? Barriers to healthcare and other social determinants of health among young women under South Africa's COVID-19 lockdown
>
J.
Jacqueline
NDIRANGU
|